At Dev4All by 4P-Pharma, we’re committed to supporting the development of new therapies for chronic and life-limiting diseases like idiopathic pulmonary fibrosis (IPF) and interstitial lung disease (ILD). Using our validated bleomycin-induced lung fibrosis model in rodents, we help clients demonstrate the therapeutic potential of their compounds with robust and translational in vivo data.
👉 For more information, contact our sales team: Daniel Sánchez López, PhD Céline Martin
